- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Tumor microenvironment and immunotherapy for triple-negative breast cancer ; volume:12 ; number:1 ; day:31 ; month:12 ; year:2024 ; pages:1-19 ; date:12.2024
Biomarker Research ; 12, Heft 1 (31.12.2024), 1-19, 12.2024
- Creator
-
Guo, Zijie
Zhu, Ziyu
Lin, Xixi
Wang, Shenkangle
Wen, Yihong
Wang, Linbo
Zhi, Lili
Zhou, Jichun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-024-00714-6
- URN
-
urn:nbn:de:101:1-2503072118419.133109573780
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guo, Zijie
- Zhu, Ziyu
- Lin, Xixi
- Wang, Shenkangle
- Wen, Yihong
- Wang, Linbo
- Zhi, Lili
- Zhou, Jichun
- SpringerLink (Online service)
Other Objects (12)
Advances in immunotherapy for triple-negative breast cancer
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Correction: Advances in immunotherapy for triple-negative breast cancer
Clinical trials of immunotherapy in triple-negative breast cancer
Spatial predictors of immunotherapy response in triple-negative breast cancer
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy
TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
Advances in immunotherapy for triple-negative breast cancer
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Correction: Advances in immunotherapy for triple-negative breast cancer
Clinical trials of immunotherapy in triple-negative breast cancer
Spatial predictors of immunotherapy response in triple-negative breast cancer
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy
TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
Advances in immunotherapy for triple-negative breast cancer
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Correction: Advances in immunotherapy for triple-negative breast cancer
Clinical trials of immunotherapy in triple-negative breast cancer
Spatial predictors of immunotherapy response in triple-negative breast cancer
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Caspase-1-dependent spatiality in triple-negative breast cancer and response to immunotherapy
TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis